X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (645) 645
Book Review (115) 115
Publication (46) 46
Conference Proceeding (14) 14
Book Chapter (7) 7
Patent (6) 6
Book / eBook (5) 5
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (457) 457
humans (389) 389
oncology (347) 347
male (228) 228
melanoma (216) 216
female (204) 204
middle aged (166) 166
aged (144) 144
cancer (143) 143
adult (133) 133
animals (123) 123
melanoma - pathology (108) 108
melanoma - drug therapy (107) 107
surgery (101) 101
skin neoplasms - pathology (86) 86
prognosis (79) 79
isolated limb perfusion (75) 75
skin neoplasms - drug therapy (72) 72
aged, 80 and over (71) 71
treatment outcome (70) 70
immunology (69) 69
melanoma - mortality (67) 67
immunotherapy (66) 66
neoplasm staging (65) 65
malignant-melanoma (63) 63
tumor necrosis factor-alpha - administration & dosage (63) 63
melphalan (62) 62
rats (62) 62
cutaneous melanoma (61) 61
interferon-gamma (60) 60
melphalan - administration & dosage (60) 60
metastatic melanoma (56) 56
hematology, oncology and palliative medicine (54) 54
survival (53) 53
medicine & public health (52) 52
care and treatment (51) 51
chemotherapy, cancer, regional perfusion (51) 51
disease-free survival (51) 51
tnf-alpha (51) 51
antineoplastic agents - therapeutic use (50) 50
skin neoplasms - mortality (50) 50
metastasis (49) 49
melanoma - surgery (48) 48
chemotherapy (47) 47
sarcoma (47) 47
tumors (46) 46
melanoma - secondary (45) 45
melanoma - therapy (44) 44
review (44) 44
therapy (44) 44
chemotherapy, cancer, regional perfusion - methods (43) 43
mice (43) 43
abridged index medicus (42) 42
tumor-necrosis-factor (42) 42
research (41) 41
survival rate (41) 41
extremities (38) 38
lymphatic metastasis (38) 38
surgical oncology (38) 38
health aspects (37) 37
adjuvant therapy (36) 36
adolescent (36) 36
antineoplastic agents - administration & dosage (36) 36
analysis (35) 35
ipilimumab (34) 34
skin neoplasms - surgery (34) 34
survival analysis (34) 34
combined modality therapy (33) 33
follow-up studies (33) 33
sarcoma - drug therapy (33) 33
antineoplastic combined chemotherapy protocols - therapeutic use (32) 32
interferon-alpha - therapeutic use (31) 31
retrospective studies (31) 31
lymph node excision (30) 30
time factors (30) 30
trial (30) 30
antineoplastic agents, alkylating - administration & dosage (29) 29
chemotherapy, adjuvant (29) 29
high-risk melanoma (29) 29
medicine, research & experimental (29) 29
combination (28) 28
factor-alpha (28) 28
interferon (28) 28
sentinel lymph node biopsy (28) 28
clinical trials (27) 27
metastases (27) 27
pharmacology & pharmacy (27) 27
risk factors (27) 27
biopsy (26) 26
prognostic-factors (26) 26
young adult (26) 26
neoplasm metastasis (25) 25
expression (24) 24
melanoma - immunology (24) 24
skin neoplasms - therapy (24) 24
clinical trials as topic (23) 23
kaplan-meier estimate (23) 23
antibodies, monoclonal - therapeutic use (22) 22
antineoplastic agents - pharmacology (22) 22
breast-cancer (22) 22
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Lancet, ISSN 0140-6736, 2005, Volume 366, Issue 9492, pp. 1189 - 1196
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 63, pp. 201 - 217
Journal Article
Nature Protocols, ISSN 1754-2189, 06/2015, Volume 10, Issue 6, pp. 904 - 915
Cell migration is a key feature of virtually every biological process, and it can be studied in a variety of ways. Here we outline a protocol for the in vitro... 
EXTRACELLULAR-MATRIX | PROLIFERATION | STABILIZATION | BIOCHEMICAL RESEARCH METHODS | MOTILITY | Cell Migration Assays - methods | Humans | Cell Migration Assays - instrumentation | Cells, Cultured | Cell research | Observations | Biological assay | Cell migration | Methods | Index Medicus
Journal Article
Journal Article
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 05/2018, Volume 15, Issue 9, pp. 1 - 2
New treatment options for patients with resected stage III melanoma have been established with the publication of the results of four pivotal randomized... 
DABRAFENIB | SURVIVAL | TRIAL | ONCOLOGY | DISSECTION | HIGH-RISK | TRAMETINIB | STAGE-III | IPILIMUMAB | Antibodies, Monoclonal, Humanized | Humans | Melanoma | Skin Neoplasms | Care and treatment | Cancer patients | Usage | Adjuvant treatment | Health aspects | Cancer | Clinical trials | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 06/2018, Volume 96, pp. 25 - 33
Journal Article